Category: Biopharmaceuticals
Global Biopharmaceuticals
-
Global Herceptin (Trastuzumab) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 5.0% from 2023 to 2029. United States market for Herceptin (Trastuzumab) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Bevacizumab Monoclonal Antibody Biosimilar Market Growth 2023-2029
... to grow at a CAGR of -15.0% from 2023 to 2029. United States market for Bevacizumab Monoclonal Antibody Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Epogen and Biosimilar Market Growth 2023-2029
... at a CAGR of -3.3% from 2023 to 2029. United States market for Epogen and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % ... Read More
-
Global Neulasta (Pegfilgrastim) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 6.7% from 2023 to 2029. United States market for Neulasta (Pegfilgrastim) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Adalimumab (Humira) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of -5.3% from 2023 to 2029. The expiration of patents for adalimumab (Humira) has emerged as a significant driver in the biosimilar market. Adalimumab is a widely used biologic medication ... Read More
-
Global Thyrogen and Biosimilar Market Growth 2023-2029
... at a CAGR of 16.3% from 2023 to 2029. United States market for Thyrogen and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % ... Read More
-
Global Avastin Biosimilar Market Growth 2023-2029
... CAGR of -15.0% from 2023 to 2029. United States market for Avastin Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through ... Read More
-
Global Enbrel (Etanercept) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 3.4% from 2023 to 2029. United States market for Enbrel (Etanercept) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Remicade (Infliximab) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 5.8% from 2023 to 2029. United States market for Remicade (Infliximab) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Rituxan (Rituximab) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 3.6% from 2023 to 2029. United States market for Rituxan (Rituximab) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Enbrel (Etanercept) Biosimilar Market Growth 2023-2029
... at a CAGR of 4.8% from 2023 to 2029. United States market for Enbrel (Etanercept) Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % ... Read More
-
Global Adalimumab Monoclonal Antibody Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 13.0% from 2023 to 2029. The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. ... Read More
-
Global BioPharmaceutical Tubing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps as well in a wide range of minimally critical invasive applications, including stent delivery systems, ... Read More
-
Bioreactor Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 13.2 Billion by 2028, exhibiting a growth rate (CAGR) of 12.1% during 2023-2028. A bioreactor refers to a fermentation vessel, wherein biological reactions are executed for developing enzymes and various organisms, including bacteria, animal cells ... Read More
-
Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... a number of factors such as patent expires of blockbuster biological drugs, lower prices, rising prevalence of chronic diseases, and cost-saving initiatives from governments and third-party payers. Catalyzed by these factors, the market is expected ... Read More
-
Active Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 303.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.6% during 2023-2028. Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of ... Read More
-
Global Biobetters Market - 2023-2030
... global biobetters market is exhibiting at a CAGR of 8.5% during the forecast period (2023-2030). The market trends of biobetters are PEGylation fusion proteins, EKylation, XTEN technology, Pasylation, and so on. Fusion proteins are created ... Read More
-
Cancer Biologics Market (Drug Class: Monoclonal Antibodies (mAb), Recombinant Proteins, Cancer Growth Inhibitors, Vaccines, CAR-T Cells, Angiogenesis Inhibitors, Interleukins (IL), and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global Cancer Biologics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Biosimilar Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type
... CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is presented from ... Read More
-
Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Service Type (Lyophilization Cycle Development, Clinical Manufacturing, Commercial Manufacturing, and Freeze Drying Analytical Services), and End User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Others)
... Companies, Research Institutes, and Others) The lyophilization services for biopharmaceuticals market is expected to grow from US$ 2.05 billion in 2022 to US$ 3.58 billion by 2028; it is estimated to register a CAGR of ... Read More
-
Biologics Outsourcing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is presented from 2018 ... Read More
-
Next Generation Biologics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is presented ... Read More
-
Global Cell Line Development for Biologics Market Growth (Status and Outlook) 2023-2029
... it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Cell Line Development for Biologics is estimated to increase from US$ million in 2022 to US$ million ... Read More
-
Global Viral Clearance Services Market Size study & Forecast, by Method (Viral Removal, Viral Inactivation), by Application (Recombinant Proteins, Tissue & Blood-Derived Products, Vaccines, Others), by End-User (Biopharmaceuticals, Contract Research Organizations, Academic Research Institutes), and Regional Analysis, 2023-2030
... Regional Analysis, 2023-2030 Global Viral Clearance Services Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than 15% over the forecast period ... Read More
-
Global Generic Pharmaceuticals Market Size study & Forecast, by Type ( Simple Generics, Specialty Generics, Biosimilars), by Application ( Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030
... and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030 Global Generic Pharmaceuticals Market is valued ... Read More
Research Assistance
